Showing results (491-500 of 10,436) with videos related to

Sort By:
Pageof 1,044
AIDS (London, England)|July 1, 2011
HIV infection perturbs interleukin-7 signaling at the step of STAT5 nuclear relocalizationIvan Landires, Florence Bugault, Olivier Lambotte, et al.
AIDS (London, England)|July 1, 2011
Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of dolutegravir as 10-day monotherapy in HIV-1-infected adultsSherene Min, Louis Sloan, Edwin DeJesus, et al.
AIDS (London, England)|July 1, 2011
Impact of lamivudine on HIV and hepatitis B virus-related outcomes in HIV/hepatitis B virus individuals in a randomized clinical trial of antiretroviral therapy in southern AfricaGail V Matthews, Prince Manzini, Zonghui Hu, et al.
AIDS (London, England)|March 23, 2011
The use of atazanavir in HIV-infected patients with liver cirrhosis: lack of hepatotoxicity and no significant changes in bilirubin values or model for end-stage liver disease scoreJose M Rodriguez, Jose M Hermida, Jose L Casado, et al.
AIDS (London, England)|March 1, 1990
Report of a WHO workshop on the measurement and significance of neutralizing antibody to HIV and SIV. London, 3-5 October 1988
AIDS (London, England)|June 18, 2011
Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in Southern AfricaOlivia Keiser, Benjamin H Chi, Thomas Gsponer, et al.
AIDS (London, England)|September 10, 2015
High completion of isoniazid preventive therapy among HIV-infected children and adults in Kinshasa, Democratic Republic of CongoMarcel Yotebieng, Andrew Edmonds, Patricia Lelo, et al.
AIDS (London, England)|September 11, 2015
Incidence and clearance of anal high-risk human papillomavirus in HIV-positive men who have sex with men: estimates and risk factorsRonald B Geskus, Cristina González, Montserrat Torres, et al.
AIDS (London, England)|January 7, 2015
Design of a highly potent HIV-1 fusion inhibitor targeting the gp41 pocketHuihui Chong, Zonglin Qiu, Yang Su, et al.
AIDS (London, England)|January 7, 2015
Mx2 expression is associated with reduced susceptibility to HIV infection in highly exposed HIV seronegative Kenyan sex workersDerek R Stein, Souradet Y Shaw, Lyle R McKinnon, et al.
Pageof 1,044